A detailed history of Ep Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ep Wealth Advisors, LLC holds 100,347 shares of ABBV stock, worth $17.6 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
100,347
Previous 91,049 10.21%
Holding current value
$17.6 Million
Previous $15.6 Million 26.9%
% of portfolio
0.18%
Previous 0.17%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $1.52 Million - $1.85 Million
9,298 Added 10.21%
100,347 $19.8 Million
Q2 2024

Aug 19, 2024

BUY
$154.79 - $180.76 $377,532 - $440,873
2,439 Added 2.75%
91,049 $15.6 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $549,620 - $626,241
3,439 Added 4.04%
88,610 $16.1 Million
Q4 2023

Feb 28, 2024

SELL
$137.6 - $154.97 $298,179 - $335,819
-2,167 Reduced 2.48%
85,171 $13.2 Million
Q3 2023

Nov 22, 2023

BUY
$133.59 - $154.65 $10.9 Million - $12.6 Million
81,488 Added 1392.96%
87,338 $13 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $11.8 Million - $14.7 Million
-89,404 Reduced 93.86%
5,850 $788,000
Q1 2023

Jun 05, 2023

BUY
$144.61 - $166.54 $184,956 - $213,004
1,279 Added 1.36%
95,254 $15.2 Million
Q4 2022

Jun 12, 2023

SELL
$138.31 - $165.87 $644,109 - $772,456
-4,657 Reduced 4.89%
90,597 $14.7 Million
Q3 2022

Dec 02, 2022

BUY
$134.21 - $153.93 $8.45 Million - $9.69 Million
62,963 Added 203.03%
93,975 $12.6 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $82,847 - $105,325
-602 Reduced 1.9%
31,012 $4.75 Million
Q1 2022

May 20, 2022

BUY
$131.98 - $163.75 $15,309 - $18,995
116 Added 0.37%
31,614 $5.13 Million
Q4 2021

Feb 17, 2022

SELL
$107.43 - $135.93 $124,296 - $157,271
-1,157 Reduced 3.54%
31,498 $4.27 Million
Q3 2021

Nov 23, 2021

SELL
$106.4 - $120.78 $376,017 - $426,836
-3,534 Reduced 9.77%
32,655 $3.52 Million
Q2 2021

Aug 24, 2021

BUY
$105.21 - $117.21 $45,766 - $50,986
435 Added 1.22%
36,189 $4.08 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $2.14 Million - $2.35 Million
20,870 Added 140.22%
35,754 $3.87 Million
Q4 2020

Feb 18, 2021

BUY
$80.49 - $108.67 $354,477 - $478,582
4,404 Added 42.02%
14,884 $1.6 Million
Q3 2020

Nov 17, 2020

SELL
$85.91 - $100.83 $45,704 - $53,641
-532 Reduced 4.83%
10,480 $918,000
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $81,734 - $109,372
-1,114 Reduced 9.19%
11,012 $1.08 Million
Q1 2020

May 18, 2020

SELL
$64.5 - $97.79 $105,973 - $160,668
-1,643 Reduced 11.93%
12,126 $924,000
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $98,313 - $123,010
1,363 Added 10.99%
13,769 $1.22 Million
Q3 2019

Nov 18, 2019

SELL
$62.98 - $75.72 $66,695 - $80,187
-1,059 Reduced 7.86%
12,406 $939,000
Q2 2019

Aug 27, 2019

BUY
$65.7 - $83.98 $292,890 - $374,382
4,458 Added 49.49%
13,465 $979,000
Q1 2019

May 20, 2019

BUY
$77.14 - $90.79 $41,115 - $48,391
533 Added 6.29%
9,007 $726,000
Q4 2018

Feb 19, 2019

SELL
$77.85 - $96.01 $38,535 - $47,524
-495 Reduced 5.52%
8,474 $781,000
Q3 2018

Nov 15, 2018

BUY
$88.91 - $98.84 $377,867 - $420,070
4,250 Added 90.06%
8,969 $848,000
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $1,885 - $2,230
-21 Reduced 0.44%
4,719 $437,000
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $127,801 - $171,138
1,389 Added 41.45%
4,740 $449,000
Q4 2017

Feb 15, 2018

SELL
$89.56 - $98.21 $1,253 - $1,374
-14 Reduced 0.42%
3,351 $324,000
Q3 2017

Nov 15, 2017

BUY
$69.85 - $89.22 $7,683 - $9,814
110 Added 3.38%
3,365 $299,000
Q2 2017

Aug 17, 2017

BUY
N/A
3,255
3,255 $236,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ep Wealth Advisors, LLC Portfolio

Follow Ep Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ep Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ep Wealth Advisors, LLC with notifications on news.